Thermo Fisher Scientific Inc. · Brief

Next report

89 days

Jan 28 · before openest.Q4 FY26

Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory

4 of 8≥ implied

avg implied: ±4.2%
avg realized: ±5.0%

Jan 30 '25±3.4%▲+6.78%×1.99

Apr 23 '25±4.2%▼−0.71%×0.17

Jul 23 '25±4.5%▲+9.14%×2.05

Oct 22 '25±4.2%▲+1.65%×0.39

Jan 29 '26±3.7%▼−2.61%×0.70

Q1 FY26±4.1%▼−9.20%×2.27

Q2 FY26±4.9%▲+8.71%×1.77

Q3 FY26±4.9%▲+0.97%×0.20

quarterimplied−10%0+10%realized×

Q3 FY26±4.9%▲+0.97%×0.20

Q2 FY26±4.9%▲+8.71%×1.77

Q1 FY26±4.1%▼−9.20%×2.27

Jan '26±3.7%▼−2.61%×0.70

Oct '25±4.2%▲+1.65%×0.39

Jul '25±4.5%▲+9.14%×2.05

2 older reports

Apr '25±4.2%▼−0.71%×0.17

Jan '25±3.4%▲+6.78%×1.99

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Jan 28 report · est.

Bull2 of 3

11customers disclosing company as a supplierSEC filings

10tracked funds holding the companyN-PORT · Aug 31 '26

Bear2

4 of 8recent reports where the move came in under options implied rangeEarnings history

13 of 24largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

TMO report session

Suppliers 1

TECHBio-Techne×0.90

Customers 1

CSTLCastle Biosciences×0.54

× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 7impliedImplied move: ±6.4% into Oct 21 earnings (Oct 7 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.